Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States.AuthorsLi, Na; Lei, Jianying; Zhang, Jiahao; Cai, Hongfu; Zheng, Bin; Yang, Ting; Liu, Maobai; Hu, JiandaPublicationTherapeutic Advances in Hematology, 2023, Vol 14, p1ISSN2040-6207Publication typeArticleDOI10.1177/20406207231168215